These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
255 related articles for article (PubMed ID: 33192175)
1. Review of the Roles and Interaction of Androgen and Inflammation in Benign Prostatic Hyperplasia. Tong Y; Zhou RY Mediators Inflamm; 2020; 2020():7958316. PubMed ID: 33192175 [TBL] [Abstract][Full Text] [Related]
2. Sex steroid receptor expression and localization in benign prostatic hyperplasia varies with tissue compartment. Nicholson TM; Sehgal PD; Drew SA; Huang W; Ricke WA Differentiation; 2013; 85(4-5):140-9. PubMed ID: 23792768 [TBL] [Abstract][Full Text] [Related]
3. Endocrine control of benign prostatic hyperplasia. La Vignera S; Condorelli RA; Russo GI; Morgia G; Calogero AE Andrology; 2016 May; 4(3):404-11. PubMed ID: 27089546 [TBL] [Abstract][Full Text] [Related]
4. Regional variations of insulin-like growth factor I (IGF-I), IGF-II, and receptor type I in benign prostatic hyperplasia tissue and their correlation with intraprostatic androgens. Monti S; Di Silverio F; Iraci R; Martini C; Lanzara S; Falasca P; Poggi M; Stigliano A; Sciarra F; Toscano V J Clin Endocrinol Metab; 2001 Apr; 86(4):1700-6. PubMed ID: 11297606 [TBL] [Abstract][Full Text] [Related]
5. Androgens and estrogens: their interaction with stroma and epithelium of human benign prostatic hyperplasia and normal prostate. Krieg M; Bartsch W; Thomsen M; Voigt KD J Steroid Biochem; 1983 Jul; 19(1A):155-61. PubMed ID: 6193338 [TBL] [Abstract][Full Text] [Related]
6. Androgens and estrogens in benign prostatic hyperplasia: past, present and future. Nicholson TM; Ricke WA Differentiation; 2011; 82(4-5):184-99. PubMed ID: 21620560 [TBL] [Abstract][Full Text] [Related]
7. Combined treatment with dihydrotestosterone and lipopolysaccharide modulates prostate homeostasis by upregulating TNF-α from M1 macrophages and promotes proliferation of prostate stromal cells. Tong Y; Guo YJ; Zhang Q; Bi HX; Kai K; Zhou RY Asian J Androl; 2022; 24(5):513-520. PubMed ID: 34975070 [TBL] [Abstract][Full Text] [Related]
8. Endogenous androgen levels in epithelium and stroma of human benign prostatic hyperplasia and normal prostate. Bartsch W; Krieg M; Becker H; Mohrmann J; Voigt KD Acta Endocrinol (Copenh); 1982 Aug; 100(4):634-40. PubMed ID: 6181638 [TBL] [Abstract][Full Text] [Related]
9. [Histological changes of the prostate and acute urinary retention in patients with benign prostatic hyperplasia]. Bao QB; He GH; Liu GY; Zhang CG; Yang C Zhonghua Nan Ke Xue; 2013 Sep; 19(9):811-4. PubMed ID: 24386860 [TBL] [Abstract][Full Text] [Related]
10. Prostatic osteopontin expression is associated with symptomatic benign prostatic hyperplasia. Popovics P; Awadallah WN; Kohrt SE; Case TC; Miller NL; Ricke EA; Huang W; Ramirez-Solano M; Liu Q; Vezina CM; Matusik RJ; Ricke WA; Grabowska MM Prostate; 2020 Jul; 80(10):731-741. PubMed ID: 32356572 [TBL] [Abstract][Full Text] [Related]
11. VAT-1 is a novel pathogenic factor of progressive benign prostatic hyperplasia. Mori F; Tanigawa K; Endo K; Minamiguchi K; Abe M; Yamada S; Miyoshi K Prostate; 2011 Oct; 71(14):1579-86. PubMed ID: 21394740 [TBL] [Abstract][Full Text] [Related]
12. [Androgen and estrogen metabolism in human benign prostatic hyperplasia (BPH)]. Krieg M; Weisser H; Tunn S Verh Dtsch Ges Pathol; 1993; 77():19-24. PubMed ID: 7511279 [TBL] [Abstract][Full Text] [Related]
13. M2a macrophage can rescue proliferation and gene expression of benign prostate hyperplasia epithelial and stroma cells from insulin-like growth factor 1 knockdown. Qian Q; He W; Liu D; Yin J; Ye L; Chen P; Xu D; Liu J; Li Y; Zeng G; Li M; Wu Z; Zhang Y; Wang X; DiSanto ME; Zhang X Prostate; 2021 Jun; 81(9):530-542. PubMed ID: 33861464 [TBL] [Abstract][Full Text] [Related]
14. Baicalin alleviates benign prostate hyperplasia through androgen-dependent apoptosis. Jin BR; An HJ Aging (Albany NY); 2020 Feb; 12(3):2142-2155. PubMed ID: 32018227 [TBL] [Abstract][Full Text] [Related]
15. Promotion of epithelial hyperplasia by interleukin-8-CXCR axis in human prostate. Smith DK; Hasanali SL; Wang J; Kallifatidis G; Morera DS; Jordan AR; Terris MK; Klaassen Z; Bollag R; Lokeshwar VB; Lokeshwar BL Prostate; 2020 Sep; 80(12):938-949. PubMed ID: 32542667 [TBL] [Abstract][Full Text] [Related]
16. Interleukin-18 may lead to benign prostatic hyperplasia via thrombospondin-1 production in prostatic smooth muscle cells. Hamakawa T; Sasaki S; Shibata Y; Imura M; Kubota Y; Kojima Y; Kohri K Prostate; 2014 May; 74(6):590-601. PubMed ID: 24615654 [TBL] [Abstract][Full Text] [Related]
17. Chronic inflammation in the pathogenesis of benign prostatic hyperplasia. Fibbi B; Penna G; Morelli A; Adorini L; Maggi M Int J Androl; 2010 Jun; 33(3):475-88. PubMed ID: 19508330 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of MENT on primary cell cultures from benign prostatic hyperplasia and prostate carcinoma. Mendoza P; Sánchez C; Contreras HR; Vergara J; Acevedo C; Cabezas J; Huidobro C; Noé G; Castellón EA Int J Androl; 2009 Dec; 32(6):607-15. PubMed ID: 18637152 [TBL] [Abstract][Full Text] [Related]
19. Mechanism of Androgen-Independent Stromal Proliferation in Benign Prostatic Hyperplasia. Hata J; Harigane Y; Matsuoka K; Akaihata H; Yaginuma K; Meguro S; Hoshi S; Sato Y; Ogawa S; Uemura M; Kojima Y Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511400 [TBL] [Abstract][Full Text] [Related]
20. Androgen receptor roles in the development of benign prostate hyperplasia. Izumi K; Mizokami A; Lin WJ; Lai KP; Chang C Am J Pathol; 2013 Jun; 182(6):1942-9. PubMed ID: 23570837 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]